BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hodak E, Lessin S, Friedland R, Freud T, David M, Pavlovsky L, Shapiro J, Cohen AD. New insights into associated co-morbidities in patients with cutaneous T-cell lymphoma (mycosis fungoides). Acta Derm Venereol. 2013;93:451-455. [PMID: 23303582 DOI: 10.2340/00015555-1496] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Kaul S, Belzberg M, Hughes JM, Mahadevan V, Khanna R, Bakhshi PR, Hong MS, Williams KA, Grossberg AL, Kwatra SG, Sweren RJ. Comorbidities in Mycosis Fungoides and Racial Differences in Co-Existent Lymphomatoid Papulosis: A Cross-Sectional Study of 580 Patients in an Urban Tertiary Care Center. Medicines (Basel) 2019;7:E1. [PMID: 31888015 DOI: 10.3390/medicines7010001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Geskin LJ, Akilov OE, Kwon S, Schowalter M, Watkins S, Whiteside TL, Butterfield LH, Falo LD Jr. Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome. Cancer Immunol Immunother 2018;67:423-34. [PMID: 29204699 DOI: 10.1007/s00262-017-2090-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Amber KT, Bloom R, Nouri K. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype. Am J Clin Dermatol. 2016;17:71-77. [PMID: 26386881 DOI: 10.1007/s40257-015-0155-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 4.4] [Reference Citation Analysis]
4 Nudelmann LM, Bonamigo RR. Primary cutaneous lymphoma in southern Brazil: a 12-year single-center experience. Int J Dermatol 2015;54:e512-20. [PMID: 26496535 DOI: 10.1111/ijd.12970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Eder J, Kern A, Moser J, Kitzwögerer M, Sedivy R, Trautinger F. Frequency of primary cutaneous lymphoma variants in Austria: retrospective data from a dermatology referral centre between 2006 and 2013. J Eur Acad Dermatol Venereol 2015;29:1517-23. [PMID: 25600184 DOI: 10.1111/jdv.12907] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Goyal A, O'Leary D, Goyal K, Patel K, Pearson D, Janakiram M. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer: A systematic review and meta-analysis. J Am Acad Dermatol 2020:S0190-9622(20)32444-0. [PMID: 32822803 DOI: 10.1016/j.jaad.2020.06.1033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ortiz-Romero PL, Servitje O, Estrach MT, Izu-Belloso RM, Fernández-de-Misa R, Gallardo F, López-Martínez N, Pérez-Mitru A. Cost of early-stage mycosis fungoides treatments in Spain. Clinicoecon Outcomes Res 2020;12:91-105. [PMID: 32104021 DOI: 10.2147/CEOR.S233376] [Reference Citation Analysis]
8 Bariani MC, Fleury LF Júnior, Ribeiro AM, Carneiro SS, Pereira TA. Mycosis fungoides and Kaposi's sarcoma association in an HIV-negative patient. An Bras Dermatol 2016;91:108-10. [PMID: 28300912 DOI: 10.1590/abd1806-4841.20164401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Aviles A, Neri N, Fernandez-diez J, Silva L, Nambo M. Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma. Hematology 2015;20:538-42. [DOI: 10.1179/1607845415y.0000000002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
10 Keto J, Hahtola S, Linna M, Väkevä L. Mycosis fungoides and Sézary syndrome: a population-wide study on prevalence and health care use in Finland in 1998-2016. BMC Health Serv Res 2021;21:166. [PMID: 33618714 DOI: 10.1186/s12913-021-06109-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen A. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2015;29:371-6. [DOI: 10.1111/jdv.12567] [Cited by in Crossref: 91] [Cited by in F6Publishing: 74] [Article Influence: 13.0] [Reference Citation Analysis]
12 Engin B, Keçici AS, Uzun AÖ, Yalçın M. Psychiatric comorbidity, depression, and anxiety levels and quality of life of the patients with mycosis fungoides. Dermatologic Therapy 2020;33. [DOI: 10.1111/dth.13922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]